Загрузка...
Ovarian cancer: emerging molecular-targeted therapies
With about 22,000 new cases estimated in 2012 in the US and 15,500 related deaths, ovarian cancer is a heterogeneous and aggressive disease. Even though most of patients are sensitive to chemotherapy treatment following surgery, recurring disease is almost always lethal, and only about 30% of the wo...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3395897/ https://ncbi.nlm.nih.gov/pubmed/22807625 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S24155 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|